Mohamed A Alhnan (MAA) is a Reader in Innovative Pharmaceutics at King’s College London (KCL). His research is focused on applying the latest advances in material science and electronics in the pharmaceutical field. His fundamental research has led to several world firsts: first example of using pharmaceutical grade polymers in FDM 3D printing (WO2017072536A1), first 3D printed tablets to meet the US and British Pharmacopoeias (BP) for delayed release products, and first examples of 3D printing of liquid-filled capsules (WO2018020237A1). He introduced and patented the innovative concept of tablets of complex architecture as a solution for fast disintegration and dissolution WO2017072536A1). Dr Alhnan invented a novel approach for manufacturing via extrusion under low temperatures (WO2016038356A1). He received over £2.5M research fund from industry and research council grants including EPSRC (EP/X013251/1, EP/V009567/1) and Innovate UK (#10121913). He received several awards including AAPS Pharmaceutical Research Meritorious Manuscript Award, Washington DC, USA for research article doi: 10.1007/s11095-016-1995-0, Eudragit Award, Best Scientific Article for 2016, Evonik, Darmstadt, Germany, and Best Research Paper Award for 2015, European Journal of Pharmaceutical Sciences (doi.org/10.1016/j.ejps.2014.11.009). Dr Alhnan has been recognised on Clarivate’s Highly Cited Researchers list for the last four consecutive years: 2021- 2025 (Of the world’s population of scientists and social scientists, Highly Cited Researchers are 1 in 1,000). MAA has published >55 peer-reviewed articles and 8 patent applications (h-index 36, >6,500 citations). Dr Alhnan laboratory  has a wide range of additive manufacturing technologies, with capacity to produce a wide spectrum of pharmaceutical dosage forms, diagnostics and medical devices.

Dr Alhnan is a Reader in Innovative Pharmaceutics since 2023. He has joined KCL as a Senior Lecturer in Pharmaceutical Medicine in the School of Cancer and Pharmaceutical Sciences in Sep 2018. Mohamed is a registered pharmacist in the UK since 2011. He worked on site-specific oral drug delivery for this PhD project in London School of Pharmacy (now UCL School of Pharmacy). After working on several industrial projects, he worked as lecturer then as a senior lecturer in the School of Pharmacy and Biomedical Sciences in University of Central Lancashire.